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Inflammation is an immune response against patho-
gens, tissue injury and surgical trauma. This response 
gives rise to the initial cardinal signs of inflammation, 
which include redness, heat, swelling, pain and loss of 
function (Serhan & Savill 2005). The study of inflamma-
tion is important because of its intimate link to other dis-
eases such as arteriosclerosis, obesity, cancer, chronic ob-
structive lung disease and asthma (Nathan & Ding 2010). 
The inflammatory process is a cascade of biochemical 
events that involves eicosanoids (prostaglandins, leukot-
rienes and thromboxanes), cytokines and infiltration of 
leucocytes (neutrophils, macrophages, mast cells and fi-
broblasts) to the injured area (Basbaum et al. 2009). Neu-
trophil migration is responsible for tissue damage and the 
interaction of neutrophils with nerve endings leads to a 
number of physiological responses during inflammatory 
reactions, including pain (Fu Sy & Gordon 1997).
The use of non-steroidal anti-inflammatory drugs 
(NSAIDS) is the most common treatment for inflam-
mation. These drugs inhibit cyclooxygenase enzymes 
(COX-1 and COX-2) and consequently reduce prosta-
glandin levels (Vonkerman et al. 2006). However, these 
compounds provoke undesirable side effects such as 
peptic ulcer formation, bleeding and perforation of the 
gastric mucosa (Silverstein et al. 1995). Glucocorticoids, 
which are alternative drugs for the treatment of chronic 
inflammation, can induce systemic adverse effects in 
chronic patients, such as adrenal insufficiency (Barnes 
2006). In this context, new drugs to treat inflammation 
with fewer side effects are necessary.
Several medicinal plants have shown promising re-
sults for alleviating pain. Many patients who use such 
treatments perceive them to be effective (Kanodia et al. 
2010). Agave sisalana Perrine ex Engelm Asparagaceae 
is a monocotyledoneous plant that is extensively culti-
vated around the world, mainly in tropical and semi-arid 
zones (Nunes-Moreira et al. 1999). In Brazil, A. sisalana 
is broadly cultivated in the state of Bahia (BA), which 
accounts for 95% of all A. sisalana grown in the country 
(Santos 2006). The crude juice of A. sisalana is produced 
by milling leaves. However, this juice is very fibrous 
and is therefore not used much. It is rich in saponins, 
which are necessary for generation of steroidal materials 
called sapogenins (specifically hecogenin and tigogenin) 
through acid hydrolysis (Ding et al. 1989). Several stud-
ies have shown different activities of extracts derived 
from the crude juice of A. sisalana. The crude juice ex-
hibits bactericidal, antihelmintic and anti-inflammatory 
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The present study evaluated the anti-inflammatory and analgesic properties of Agave sisalana Perrine in clas-
sic models of inflammation and pain. The hexanic fraction of A. sisalana (HFAS) was obtained by acid hydrolysis 
followed by hexanic reflux. Anti-inflammatory properties were examined in three acute mouse models (xylene ear 
oedema, hind paw oedema and pleurisy) and a chronic mouse model (granuloma cotton pellet). The antinociceptive 
potential was evaluated in chemical (acetic-acid) and thermal (tail-flick and hot-plate test) models of pain. When 
given orally, HFAS (5, 10, 25 and 50 mg/kg) reduced ear oedema (p < 0.0001; 52%, 71%, 62% and 42%, respectively). 
HFAS also reduced hind paw oedema at doses of 10 mg/kg and 25 mg/kg (p < 0.05; 42% and 58%, respectively) and 
pleurisy at doses of 10 mg/kg and 25 mg/kg (41% and 50%, respectively). In a chronic model, HFAS reduced inflam-
mation by 46% and 58% at doses of 10 mg/kg and 25 mg/kg, respectively. Moreover, this fraction showed analgesic 
properties against the abdominal writhing in an acetic acid model (at doses of 5-25 mg/kg) with inhibitory rates of 
24%, 54% and 48%. The HFAS also showed an increased latency time in the hot-plate (23% and 28%) and tail-flick 
tests (61% and 66%) for the 25 mg/kg and 50 mg/kg doses, respectively. These results suggest that HFAS has anti-
inflammatory and analgesic properties.
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activity (Santos et al. 2009, Botura et al. 2010, Dunder et 
al. 2010). In the Dominican Republic, a traditional medi-
cine called Agave intermixta Trel is widely used in the 
treatment of arthritis and infections (Garcia et al. 1999).
Based on other studies of sapogenins obtained from 
the Agave genus in inflammation research, the present 
study was conducted to investigate the possible anti-
inflammatory and antinociceptive effects of the hexanic 
fraction of A. sisalana (HFAS) obtained from the hydro-
lysed extract.
MATERIALS AND METHODS
Drugs and chemicals - Acetic acid, xylene, metha-
nol (Merck, Brazil), dexamethasone (DEXA) (Hoechst 
SA, Brazil), ethanol, standard hecogenin, polyethylene 
glycol-200, morphine hydrochloride, sufentanil, car-
rageenan and indomethacin (INDO) (Sigma Chemical 
Co, St. Louis, MO, USA) were used in the present study. 
Morphine was dissolved in a 0.9% NaCl solution just 
before use and INDO was prepared in a sodium bicar-
bonate solution (5%). HFAS was dissolved in a solution 
of polyethylene glycol-200 (40%, vehicle). All of the rea-
gents used were of high purity.
Plant material - The A. sisalana was cultivated at 
the Riacho do Cedro farm located in the city of Santo 
Domingo in BA. The botanical identification was per-
formed by Jorge Tamashiro and a voucher specimen was 
deposited at the herbarium at the State University of 
Campinas (UNICAMP) (Campinas, state of São Paulo) 
(voucher 150.429). The leaves were crushed for separa-
tion of the juice and for acquisition of the fibre. The A. 
sisalana crude juice was donated by Corona Comércio e 
Indústria Ltda (Salvador - BA).
Fraction preparation - HFAS was obtained from 
the A. sisalana crude juice, according to the protocol of 
Peana et al. (1997) with some modifications. To obtain 
a higher concentration, the A. sisalana juice was evapo-
rated at 100ºC until it was reduced to 1/10 of its initial 
volume. The crude juice (40 g) was subjected to reflux 
with 300 mL of HCl for 4 h with agitation. After cool-
ing at room temperature, the dark precipitate that formed 
was filtered, washed with water, neutralized with 10% 
NaOH and dried. The resulting powder was refluxed 
with 300 mL of hexane at 60ºC for approximately 60 h. 
The hexanic solution was filtered and evaporated to pro-
vide 1 g (2.5%) of green powder that was rich in steroidal 
sapogenins. This powder was named HFAS.
Chemical analysis - HFAS was qualitatively analysed 
by high-performance liquid chromatography (HPLC). 
HFAS as the standard hecogenin and the mixture of 
HFAS and the standard hecogenin were solubilised in 
methanol. The solution (20 μL, 1 mg/mL) was then in-
jected into the HPLC apparatus (Shimadzu-LC 10, Japan) 
with a column (ACE 5 C 18, 250.0 x 4.6 mm x 5 μm). The 
mobile phase was methanol (0.6 mL/min for 15 min) for 
ultraviolet detection (254 nm). The quantitative analysis 
was performed by standard methods, using a multilevel 
calibration curve determined by analysis of a pure heco-
genin solution at known concentrations (1-10 mg/mL).
Cell culture - The mouse fibroblast cell line BALB/c 
3T3 was cultivated in Dulbecco’s Modified Eagle’s Me-
dium medium supplemented with 10% foetal bovine se-
rum, 1% penicillin (100 U/mL) and streptomycin (100 
g/mL) and incubated at 37ºC under 5% CO2. All of the 
tests were performed in duplicate.
Animals - All of the experiments were performed 
on male Unib-WH rats (160 ± 200 g) and male Unib-
SW mice (30 ± 5 g) from the Animal House of Multi-
disciplinary Center for Biological Research/UNICAMP. 
The animals were fed a diet of regular rodent chow and 
had free access to tap water. The animals were housed 
on a 12-h light: 12-h dark cycle at 50% humidity and a 
temperature of 24 ± 1ºC. All of the experiments were 
performed in the morning. The experimental protocols 
were approved by the Animal Use and Care Committee 
of UNICAMP, protocol 1281-1.
Cell toxicity assay [(2-methoxy-4-nitro-5-sulphophe- 
nyl)-2H-tetrazolium-5-carboxanilide (MTT)] - The cy-
totoxicity of HFAS was determined using a colorimet-
ric method (Mosmann 1983). This method assesses the 
ability of the mitochondrial enzyme succinate dehydro-
genase in viable cells to convert MTT into formazan. 
BALB/c 3T3 cells were seeded on 96-well culture plates 
at a density of 1 × 104 cells/well. The cells were then 
incubated for 24 h. After this incubation, the cells were 
treated with increasing concentrations of HFAS (0-500 
μM) for 24 h at 37ºC. The culture medium was then 
replaced by fresh medium containing 0.5 mg/mL MTT 
and the plates were incubated for 4 h at 37ºC. The me-
dium was then removed and was replaced by 100 μL of 
ethanol for the solubilisation of formazan. The absorb-
ance was measured using a spectrophotometric micro-
plate reader (ELx 800 BIO-TEK) at a wavelength of λ = 
570 nm. The cell viability was expressed as the relative 
formazan formation in the treated samples relative to 
the control cells.
Xylene-induced ear swelling in mice - This assay was 
performed as previously described (Núñez Guillén et al. 
1997). The Unib-SW (n = 8) mice were separated into 
groups. The experimental groups received HFAS [5, 10, 
25 and 50 mg/kg orally (p.o.)] and the controls received 
vehicle (10 mL/kg) and INDO (5 mg/kg). After 1 h of 
treatment, each animal received 30 μL of xylene on the 
anterior and posterior surfaces of the left ear lobe. The 
right ear was considered to be the control. One hour later, 
the animals were sacrificed by cervical dislocation and 
circular sections with a diameter of 8 mm were obtained 
from ears and weighed. The degree of ear swelling was 
calculated based on the weight of the right ear, which did 
not undergo xylene application.
Carrageenan-induced rat hind paw oedema - In-
flammation in the hind paw was induced as previously 
described (Winter et al. 1962). Male Unib-WH rats were 
divided into six groups (n = 5). The groups received 
HFAS at 5, 10, 25 and 50 mg/kg doses (p.o.) and the 
controls received vehicle (10 mL/kg) or DEXA (5 mg/kg 
p.o.). One hour after treatment, 0.2 mL of λ-carrageenan 
(1%) was administered to the sub-plantar region. The 
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paw oedema volume was measured using a plethysmom-
eter (UGO Basile, Italy) to determine the oedema at ½, 1 
h, 2 h, 3 h and 4 h after λ-carrageenan administration.
Granuloma cotton pellet - The test for cotton pellet-
induced granuloma formation was performed as de-
scribed in a previous study (Swingle & Shideman 1972). 
Male Unib-WH rats (n = 7) received HFAS (10 and 25 
mg/kg, the best doses for acute treatment) or the control 
treatment (vehicle or DEXA 0.5 mg/kg p.o.) once daily 
for seven days. A sterilised cotton pellet weighing 20 
mg was placed subcutaneously into the back region of 
rats on the first day. The animals were sacrificed on the 
eighth day. The pellets were removed with the granulo-
ma tissue and dried at 60ºC. The dry weights were then 
determined. The percent inhibition was expressed by 
comparing the mean weight in the test groups with that 
of the negative control group.
Induction of pleurisy - Groups of UNIB-WH rats were 
given HFAS p.o. (10 mg/kg and 25 mg/kg) and the con-
trols were given DEXA (2.0 mg/kg) or vehicle (10 mL/
kg). One hour after treatment, the animals were slightly 
anesthetised with isofluorane and 0.2 mL of a sterile solu-
tion (consisting of 1% carrageenan suspended in sterile 
saline) was injected into the right pleural cavity. The ani-
mals were killed by CO2 4 h after the induction of pleurisy. 
The pleural exudate from each animal was harvested by 
washing the pleural cavity with 5 mL of sterile phosphate 
buffered saline solution containing 5 U/mL heparin. The 
exudates with blood contamination were rejected. The 
total leucocytes in each sample were counted after Turk 
staining (2 mL of acetic acid, crystal violet 1%, 1 mL of 
methanol and 97 mL of water) using a Neubauer count-
ing chamber. The differential cell count in each sample of 
pleural fluid was determined by haematoxylin and eosin 
staining, according to a previous study (Mikami & Miya-
saka 1983), with some modifications.
Measurement of myeloperoxidase (MPO) levels - 
Samples of the fluid leakage were collected immediately 
after the pleural cavity was opened for the MPO assay. 
The pleural lavage (40 mL) or the standards (MPO from 
human neutrophils; Sigma M-6908: 0.7-140 mU/mL) were 
transferred to cuvettes and the reaction was initiated by 
the addition of 360 mL of assay buffer (0.167 mg/mL of 
o-dianisidine 2HCl and 0.0005% H2O2). The enzymatic 
reaction was stopped by adding 1% sodium azide after 
15 min. Afterwards, the samples were centrifuged (50 g 
for 5 min) and the supernatants were separated. The rate 
of change in absorbency at 450 nm was determined by 
using a spectrophotometer (Hitachi U-2001 model 121-
0031, Tokyo, Japan). The samples in which the levels of 
MPO were higher than the upper limit of detection (140 
µg/mL) were diluted (2-5-fold) and the concentrations 
were corrected for the two-five-fold dilution. The results 
below the lower limit of detection were expressed as 0.7 
µg/mL (Fröde-Saleh & Calixto 2000).
Acetic acid-induced writhing - Male Unib-SW (n = 8) 
mice were used according to a method described previ-
ously (Koster et al. 1959). The total number of writhing 
events following intraperitoneal administration of 0.6% 
acetic acid was recorded for 15 min, starting 5 min af-
ter injection. The animals were pre-treated with HFAS at 
doses of 5, 10, 25 and 50 mg/kg (p.o.) and the controls were 
pre-treated with vehicle (10 mL/kg) and INDO (5 mg/kg 
p.o.) 1 h before acetic acid administration. Antinocicep-
tive activity was expressed as a reduction of the number of 
abdominal writhes relative to the negative control.
Hot-plate test - The hot-plate test was used to meas-
ure the latency of the response as described previously 
(Eddy & Leimbark 1953) with minor modifications. The 
temperature of the hot-plate (Ugo Basile, Models-DS 37) 
was maintained at 56 ± 1ºC. The Unib-SW (n = 8) mice 
were placed in a glass cylinder with a diameter of 24 
cm on a heated surface. The time between the placement 
and licking of the paws or jumping was recorded as the 
latency. Control mice were treated with vehicle (vehicle, 
10 mL/kg). Morphine was used as a positive control (10 
mg/kg subcutaneously) and HFAS was administered (5, 
10, 25 and 50 mg/kg p.o.). All of the substances were 
administered 30 min before the beginning of the experi-
ment. The mice were selected 24 h before the experiment 
on the basis of their reactivity to the test. This response 
was defined as the baseline (BL). All of the mice were 
observed before and 30, 60, 90 and 120 min after drug 
administration. A latency of 20 s was defined as com-
plete analgesia. The result was expressed as the percent-
age of the maximal possible effect (MPE), according to 
the following equation with the following definitions: 
test line (TL) [value of paw cut-off (CO) during the ex-
periment], BL (response obtained 24 h before the experi-
ment) and CO (maximum latency time of 20 s):
MPE (%) = { TL - BL } x 100           CO - BL 
Tail flick test - We used the tail-flick test, which is 
another assay to evaluate the antinociceptive effect, as 
previously described (Ness & Gebhart 1986). Unib-SW 
mice received HFAS at doses of 5, 10, 25 and 50 mg/
kg or they received the controls vehicle (10 mL/kg) or 
sufentanil (5 µg/kg intramuscularly). Briefly, the mice 
were gently held with the tail positioned in the tail-flick 
apparatus (Ugo Basile, Italy) for radiant heat stimulation 
(50 ± 5ºC) of the ventral surface of the tail. The intensity 
of the heat stimulus was adjusted to cause the animal to 
flick its tail within 2-3 s as the BL for the tail-flick laten-
cy. All tail-flick latencies were converted to a percentage 
of the MPE according to the following equation with the 
following definitions: TL (value of tail-flick CO during 
the experiment), BL (response obtained 24 h before the 
experiment) and CO (maximum latency time of 10 s).
MPE (%) = { TL - BL } x 100           CO - BL 
Statistical analysis - The results are presented as the 
mean ± standard deviation (SD). Statistical comparison 
of the data was performed using the analysis of vari-
ance (ANOVA), followed by Dunnett’s test. p < 0.05 
were considered significant. The statistical analysis was 
performed using Graphpad Prisma 5.0 software (Graph-
Pad®, San Diego, CA, USA).
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RESULTS
Chemical analysis - According to the HPLC chroma-
tography analyses, we observed the same retention time 
(RT) for standard hecogenin (RT = 4.34265) (Fig. 1A, 
B). The other peak in the HFAS is probably tigogenin 
(RT = 4.9677), because of the literature describes the 
genus Agave as being rich in hecogenin and tigogenin 
(Peana et al. 1997). As shown in Fig. 1C, a mixture of 
HFAS and the standard hecogenin was injected into the 
HPLC. The graph shows the peak of hecogenin in the 
same RT. The HPLC quantitative analysis in comparison 
with standard hecogenin revealed that HFAS contains 
50% of this compound.
MTT test - Fig. 2 shows the effect of HFAS on the mi-
tochondrial function (reduction of MTT) in BALB/c 3T3 
cells. Cells treated with HFAS (250-500 μM) showed a 
15% reduction in MTT when compared with the control 
group, which did not receive HFAS.
Xylene-induced ear swelling in mice - Oral adminis-
tration of HFAS significantly suppressed xylene-induced 
ear oedema in mice (Fig. 3). The oedema inhibition pro-
duced by HFAS was 52%, 71%, 62% and 42% at doses of 
5, 10, 25 and 50 mg/kg, respectively. The reference drug 
(INDO, 5 mg/kg) exhibited 78% inhibition relative to 
the negative control (vehicle).
Carrageenan-induced rat hind paw oedema - The 
results of another acute inflammatory test (carrageenan-
induced rat hind paw oedema) are shown in Fig. 4. HFAS 
(at doses of 10 and 25 mg/kg) exhibited significant inhi-
bition (42% and 58%) of carrageenan-induced rat paw 
oedema. DEXA produced a 64% reduction in anti-in-
flammatory activity 4 h after carrageenan injection.
Granuloma cotton pellet - In the chronic model of 
granuloma (cotton pellet), HFAS inhibited granuloma 
formation relative to the negative control (vehicle). HFAS 
(10 and 25 mg/kg) produced 46% and 58% reductions 
in granuloma weight, respectively. The positive control 
(DEXA) showed 90% reduction (Fig. 5).
Pleurisy - The values for the estimated amount of 
cells in the pleural cavity (Table I) show that both of the 
HFAS doses tested (10 and 25 mg/kg) produced a reduc-
tion in total cell infiltration (41% and 50%, respectively). 
The positive control DEXA produced a 76% reduction 
in infiltration. HFAS treatment resulted in neutrophil 
reduction (55% and 62% for the 10 and 25 mg/kg doses, 
respectively). For the mononuclear cells, a dose of only 
25 mg/kg produced a 34% reduction and the positive 
control DEXA showed a 48% reduction.
Measurement of MPO levels - Fig. 6 shows the re-
sults from the MPO pleural lavage obtained from the 
carrageenan-induced pleurisy in the experimental mod-
el. A dose of 25 mg/kg produced a significant decrease 
in the MPO pleural lavage (43%) and the positive control 
DEXA (2.5 mg/kg) showed a significant reduction (84%, 
p < 0.0001) relative to the negative control (vehicle).
Acetic acid-induced writhing - The antinocicep-
tive effects were assessed using the acetic acid-induced 
writhing test. HFAS significantly reduced the number 
of writhing events induced by acetic acid solution at in-
hibitory rates of 24%, 54% and 48%. The standard drug 
Fig. 1B: high-performance liquid chromatography chromatograms of 
standard hecogenin in only peak samples at ultraviolet detection (254 
nm). mAU: mass absorbance unit.
Fig. 1C: high-performance liquid chromatography chromatograms 
of mixture of hexanic fraction of Agave sisalana and standard heco-
genin. This figure showed the same peak for hecogenin samples at 
ultraviolet detection (254 nm). mAU: mass absorbance unit.
Fig. 1A: high-performance liquid chromatography chromatograms 
of hexanic fraction of Agave sisalana samples at ultraviolet detection 
(254 nm), hecogenin in the first peak and tigogenin is the second peak. 
mAU: mass absorbance unit.
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(INDO) inhibited 45% of writhing. These results are 
shown in Table II.
Hot-plate test - The results of the hot plate test (Table 
III) show that HFAS (50 mg/kg) increased the latency time 
after 90 min (28%) and after 120 min at doses of 10, 25 
and 50 mg/kg (20, 23 and 28%, respectively). The standard 
drug (morphine, 10 mg/kg) showed an increased latency 
time at 30 min (56%), 60 min (72%) and 90 min (71%).
Tail-flick test - In the tail flick test, HFAS also pro-
duced an increased latency time by MPE. Doses of 10, 25 
and 50 mg/kg increased the latency time from 60 min on. 
HFAS showed MPE rates of 42%, 61.5% and 66% for dos-
es of 10, 25 and 50 mg/kg, respectively. Sufentanil, which 
was applied as the standard drug, increased the latency 
time of the test (85%). The results are shown in Table IV.
DISCUSSION
Natural products, including plant derivatives, have 
over the years contributed to the discovery of new 
therapeutic drugs. Most secondary plant metabolites 
are known to interfere with or act on several mediators 
of inflammation (Calixto et al. 2003). In this study, we 
evaluated the potential of A. sisalana, which is rich in 
steroidal sapogenins, in classic models of inflammation. 
Chemical HPLC analyses confirmed the presence of 
hecogenin and tigogenin in HFAS, showing the same RT 
relative to the standard hecogenin. A quantitative analy-
sis based on the standard hecogenin curve revealed that 
HFAS contains hecogenin as the major compound.
The MTT cell viability test was used to evaluate the 
toxicity of HFAS. This method assesses the ability of vi-
able cells to convert MTT into formazan by the mitochon-
drial enzyme succinate dehydrogenase. Our results clear-
ly showed that HFAS did not induce mortality of BALB/c 
3T3 cells at concentrations of 50-500 μM. Furthermore, 
the MTT test did not reach the 50% inhibitory concentra-
tion, which shows that HFAS is not toxic. After HFAS 
was confirmed to be non-toxic, further analysis of its anti-
inflammatory and analgesic activities was performed.
The anti-inflammatory activity of HFAS was eval-
uated by using a xylene-induced mouse ear oedema 
model. Xylene acts in the early phase of inflammation 
Fig. 2: effects of hexanic fraction of Agave sisalana (HFAS) on the 
cytotoxicity of cells BALB/c 3T3. Cells were grown in a Dulbecco’s 
Modified Eagle’s Medium medium with vehicle-control (dimethyl 
sulfoxide) or 50-500 µM of HFAS for 24 h. The number of viable 
cells was determined by an (2-methoxy-4-nitro-5-sulphophenyl)-2H-
tetrazolium-5-carboxanilide assay. 
Fig. 3: inhibitory effects of hexanic fraction of Agave sisalana (HFAS) 
at different doses (5, 10, 25 and 50 mg/kg) on the weight of ear oedema 
in xylene-induced ear inflammation. The control group received ve-
hicle solution and the reference drug was indomethacin (INDO) (5 
mg/kg). Asterisks (p < 0.0001 values) mean means ± standard devia-
tion compared with vehicle control group (one-way analysis of vari-
ance followed by Dunnet’s post hoc test).
Fig. 4: inhibitory effect induced by hexanic fraction of Agave sisalana 
(HFAS) (5, 10, 25 and 50 mg/kg) on the oedema induced by carra-
geenan in rats. The control group received vehicle (10 mL/kg) and 
the reference drug was dexamethasone (DEXA) (2 mg/kg). Asterisk 
(p < 0.05 values) means means ± standard deviation compared with 
vehicle control group (one-way analysis of variance followed by Dun-
net’s post hoc test).
Fig. 5: inhibitory effects of hexanic fraction of Agave sisalana (HFAS) 
(10 and 25 mg /kg) in cotton pellet model. Vehicle dexamethasone 
(DEXA) (0.5 mg/ kg) was a negative and positive control. Values rep-
resent means ± standard deviation. Asterisks mean p < 0.0001 (one-
way analysis of variance followed by Dunnet’s post hoc test).
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through several events such as vasodilatation and re-
lease of histamine, serotonin and substance P. These 
mediators can induce ear oedema by increasing vascular 
permeability (Hosseinzadeh et al. 2003). In our study, 
HFAS showed anti-oedematogenic activity by reducing 
xylene ear oedema. These results suggest that HFAS can 
decrease oedema because it contains the steroidal mol-
ecules hecogenin and tigogenin. The anti-inflammatory 
activity was corroborated by another experiment that 
measured hind paw oedema in a classical model of acute 
inflammation, which is a good model to examine the 
anti-inflammatory effects of natural products.
The inflammatory response in the hind paw assay 
involves two phases. The first phase involves the release 
of serotonin and histamine and the second phase is me-
diated by prostaglandin E2 (PGE2), which is a product of 
COX (Torres et al. 2000). Previous studies showed that 
neutrophil infiltration and activation are involved in the 
inflammatory responses induced by carrageenan (Godin 
et al. 2011). HFAS reduced oedema at doses of 10 and 25 
mg/kg, which suggests that HFAS may play a key role 
in decreasing levels of histamine, serotonin and other 
inflammatory mediators in xylene-induced ear oedema. 
HFAS maintained the reduction of oedema during the 
second phase, which involves PGE2 and leukocyte in-
filtration. Another study (Dunder et al. 2010) showed 
that hydrolysed extracts of A. sisalana inhibited oedema 
in the same model, but at a higher dose. In the present 
study, with a more purified compound that is richer in 
steroidal sapogenins, more promising results were ob-
tained with lower doses.
Another parameter of inflammation is cellular in-
filtration. When injected into the pleural cavity, car-
rageenan (the flogistic agent) causes tissue damage, 
plasma exudation and protein-rich fluid accumulation 
followed by an influx of leukocytes (Murai et al. 2003). 
Therefore, carrageenan-induced acute inflammation has 
been linked to neutrophil infiltration and the production 
of neutrophil-derived free radicals (Impellizzeri et al. 
2011). The recruitment and activation of neutrophils at 
the site of inflammation contributes to the release of in-
flammatory mediators, which increase vascular perme-
ability, maintain inflammation and cause tissue damage 
(Farias et al. 2012). The present data show that HFAS is 
able to attenuate leukocyte infiltration into the pleural 
cavity. HFAS was shown mainly block neutrophil influx 
rather than influencing mononuclear cells at 4 h after 
induction with carrageenan. This response may explain 
the reduction of hind paw oedema. Neutrophils release 
different inflammatory mediators, such as MPO, which 
is a member of the peroxidase-COX superfamily that 
is abundantly expressed in neutrophils and to a lesser 
extent in monocytes and certain types of macrophages. 
MPO participates in innate immune defence mechanisms 
through the formation of microbicidal reactive oxidants 
and diffusible radical species involved in inflammation 
(Malle et al. 2007). A biochemical analysis revealed that 
HFAS reduced the levels of MPO. These data indicate 
that anti-inflammatory drugs may also exert their ef-
fects via inhibition of MPO pathways.
To test the anti-inflammatory activity in a chronic 
model of inflammation (the cotton pellet granuloma 
model), the most effective doses of HFAS (10 and 25 mg/
kg) were chosen from the acute models of inflammation. 
The cotton pellet granuloma method is widely employed 
to assess efficacy against the proliferative phase of in-
flammation in which tissue degeneration and fibrosis 
occur (Swingle & Shideman 1972). The evaluated doses 
of HFAS reduced the proliferative phase of inflamma-
TABLE I
Effect of hexanic fraction of Agave sisalana (HFAS) on carrageenan-induced pleurisy in rats
Groups



















Vehicle - - 2.86 ± 0.74 - 1.18 ± 0.29 -
DEXA 0.9 ± 0.13a 76 0.29 ± 0.07a 90 0.61 ± 0.14a 48
HFAS 10 2.25 ± 0.48a 41 1.29 ± 0.30a 55 0.98 ± 0.19 17
HFAS 25 1.89 ± 0.48a 50 1.08 ± 0.31a 62 0.78 ± 0.16b 34
a: p < 0.001; b: p < 0.05. Data represent means ± standard deviation values from eight-10 rats. DEXA: dexamethasone.
Fig. 6: inhibitory effects of hexanic fraction of Agave sisalana (HFAS) 
(10 and 25 mg/kg) in biochemical quantifications of myeloperoxidase 
(MPO) in µg/mL. Vehicle and dexamethasone (DEXA) (2.5 mg/kg) 
was a negative and positive control. Values represent by means ± stan-
dard deviation. *: p < 0.05; *** p < 0.0001 (one-way analysis of vari-
ance followed by Dunnet’s post hoc test).
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tion, which involves cellular infiltration of leucocytes 
such as neutrophils and macrophages into the inflam-
mation site, followed by fibroblast infiltration (Swingle 
& Shideman 1972). The present results show that by re-
ducing the proliferative phase, HFAS plays an important 
role in leucocyte regulation, mainly in neutrophil cells.
Pain is intimately linked to inflammation because 
some inflammatory mediators stimulate nociceptors, 
which results in painful sensations. The present results 
showed that oral administration of HFAS caused an an-
tinociceptive effect against acute chemical and thermal-
induced nociception in mice. Three different analgesic 
assays were used, including acetic acid-induced writh-
ing and the hot plate and tail flick tests.
In the acetic acid-induced abdominal writhing test 
(a visceral pain model) arachidonic acid is released via 
COX. Additionally, prostaglandin biosynthesis plays a 
role in this nociceptive mechanism (Franzotti et al. 2002). 
Furthermore, this model releases other mediators such as 
bradykinin and substance P, as well as cytokines such 
as interleukin (IL)-1β, tumour necrosis factor alpha and 
IL-8 (Sekiya et al. 1982). HFAS reduced the number of 
writhing events. In this test, HFAS was as effective as the 
standard drug INDO in reducing the amount of abdomi-
nal writhing, which indicates its antinociceptive activity.
The hot-plate and tail-flick tests were performed to 
assess whether HFAS possesses central analgesic prop-
erties. The results of the hot-plate test indicate that HFAS 
(at doses of 25 and 50 mg/kg) significantly increased the 
latency of the response, which suggests that this com-
pound suppressed the thermal stimulus response.
This latency increase was confirmed by the tail-flick 
test, in which a thermal stimulus is focused on the tail 
skin of the animal to activate nociceptors in the super-
ficial layers of the skin. The activation of peripheral no-
ciceptors triggers a complex series of processes at the 
spinal level and results in the tail flick response. The 
tail-flick also activates the transient receptor potential 
vanilloid (TRPV)1 vanilloid receptor. TRPV1 expression 
in the skin is localized to the terminals of intracutaneous 
epidermal nerve fibres that convey pain sensations gen-
erated by noxious heat (Mandadi & Roufogalis 2008). 
Activation of TRPV1 receptors induces eicosanoid for-
mation and releases other pro-inflammatory mediators. 
The eicosanoids, mainly PGE2, promote a secondary ac-
tivation of TRPV1 (Dogrul et al. 2007).
HFAS increased the latency time in the tail-flick test, 
which corroborated the results of the hot-plate test. Some 
sapogenins have antinociceptive activity. For example, 
hederagenin and oleanolic acid (derived from Akebia 
quinata) showed analgesic properties in the same mod-
els (Choi et al. 2005). Compounds with steroidal char-
TABLE II
Effects of the hexanic fraction of Agave sisalana (HFAS)  
on acetic acid-induced writhing in mice



















a: p < 0.0001; b: p < 0.01 (one-way analysis of variance followed 
by Dunnet’s post hoc test). The control group received vehicle 
(10 mL/kg) and the reference drug was indomethacin (INDO) 
(10 mg/kg). Values represent means ± standard deviation.
TABLE III
Analgesic effects of hexanic fraction  
of Agave sisalana (HFAS) in hot-plate test in mice
Groups
Maximal possible effect 
(%)
Dose 30 min 60 min 90 min 120 min
Vehicle 10 mL/kg 2 5.25 4.4 5.2
Morfine 10 mg/kg 56a,c 72a,c 21 11
HFAS 5 mg/kg 7 11 17 16
HFAS 10 mg/kg 19 27 19 20b
HFAS 25 mg/kg 18 15 17 23a
HFAS 50 mg/kg 17 23 28b 28a
a: p < 0.0001; b: p < 0.01; c: p < 0.05 comparison morphine 
and HFAS (one-way analysis of variance followed by Dunnet’s 
post hoc test). Vehicle and morphine (10 mg/ kg) was a respec-
tively negative and positive control. 
TABLE IV
Analgesic effects of hexanic fraction  















0 - - - - - -
15 -2,0 90.6a,d 14.1 37.5 18.7 37.2
45 -10.9 95.3b,d 9 37.5 42.8a 66.2a
60 -10.9 95b,d 15.7 29.2a 61.5c 40.7a
90 0.8 100b,d 13.6 41.8a 55.2a 27.4a
120 -6.5 67.7c,d 12.8 29.9 41.7a 47.6a
180 -7.9 49.1c,d 7.3 25.8 34.1a 49.3a
240 5.3 48.3c,d 13.6 6.3 15.9 11.5
a: p < 0.0001; b: p < 0.01: c: p < 0.05; d: p < 0.05 comparison 
sufentanil and HFAS (one-way analysis of variance followed 
by Dunnet’s post hoc test). Vehicle and sufentanil as negative 
and positive control. 
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acteristics have analgesic activities, but the underlying 
mechanism is still not well understood. However, Cunha 
et al. (2008) described an important role of neutrophils 
in mechanical inflammatory nociception. Furthermore, 
another study demonstrated that the thermal hyperalge-
sic response was impaired by blockade of neutrophil re-
cruitment (Lavich et al. 2006). Based on these pre-clini-
cal studies involving inflammation and pain, we believe 
that the analgesic effects of HFAS involve leucocyte in-
filtration, mainly neutrophil infiltration.
In summary, a chemical analysis identified two ster-
oidal sapogenins in HFAS (hecogenin and tigogenin) 
with low toxicity. Results obtained in vivo conclude that 
this compound is crucial for leucocyte infiltration in 
acute tests. We also showed that HFAS has anti-oedema-
togenic properties. In chronic models of inflammation, 
HFAS showed a slight stronger activity relative to the 
positive control DEXA. Finally, we showed that HFAS 
has analgesic properties. Our data provide a scientific 
basis for new uses of A. sisalana in therapeutic studies 
and new applications for the crude juice. New tests are 
being performed to identify the mechanisms of action 
for HFAS in inflammatory and analgesic studies.
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